Citadel Advisors
SBC

Citadel Advisors’s SBC Medical Group SBC Stock Holding History

Citadel Advisors’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$446K Buy
+144,718
New +$491K ﹤0.01% 10151
2025
Q3 		– Sell
-29,366
Closed -$136K – 14445
2025
Q2 		$136K Buy
+29,366
New +$116K ﹤0.01% 11050

Other funds holding SBC

LK
Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Citadel Advisors's SBC Position: Q2 2026 in Review

Citadel Advisors opened a new position in SBC Medical Group (SBC) in Q2 2026: 144,718 shares worth $446K. The stake represents ﹤0.01% of the portfolio and ranks #10151 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in SBC as recently as Q2 2025.

Citadel Advisors first reported a position in SBC in Q2 2025 and has held it in 2 quarters since. 56 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • Citadel Advisors held 144,718 shares of SBC Medical Group worth $446K as of Q2 2026.
  • SBC Medical Group was a new Citadel Advisors position in Q2 2026.
  • SBC Medical Group made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #10151 holding.
  • Citadel Advisors first reported a position in SBC Medical Group in Q2 2025 and has held it in 2 quarters since.
  • 56 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.